Control mechanisms of human basophil releasability.
D000367:Age Factors; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D001249:Asthma / Q000276:immunology; D001491:Basophils / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D003876:Dermatitis, Atopic / Q000235:genetics / Q000276:immunology; D003903:Deuterium / Q000494:pharmacology; D017666:Deuterium Oxide; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D006967:Hypersensitivity / Q000235:genetics / Q000276:immunology*; D007073:Immunoglobulin E / Q000032:analysis / Q000276:immunology / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D010641:Phenotype; D014867:Water / Q000494:pharmacology
D000888:Antibodies, Anti-Idiotypic; C026408:anti-IgE antibodies; D014867:Water; D007073:Immunoglobulin E; D000001:Calcimycin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D003903:Deuterium; D017666:Deuterium Oxide